JPL Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.4K Buy
398
+1
+0.3% +$196 0.02% 191
2026
Q1
$77.8K Buy
+397
New +$77.1K 0.02% 183
2025
Q4
Sell
-387
Closed -$73.8K 376
2025
Q3
$73.8K Buy
+387
New +$68.7K 0.02% 206

Other funds holding DGX

JPL Wealth Management's DGX Position: Q2 2026 in Review

JPL Wealth Management increased its Quest Diagnostics (DGX) stake by 0.25% in Q2 2026, buying an estimated $196 and bringing the position to 398 shares worth $84.4K. The position accounts for 0.02% of the portfolio, ranked #191.

JPL Wealth Management first reported a position in DGX in Q3 2025 and has held it in 3 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • JPL Wealth Management held 398 shares of Quest Diagnostics worth $84.4K as of Q2 2026.
  • JPL Wealth Management bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up 0.02% of JPL Wealth Management's portfolio in Q2 2026, its #191 holding.
  • JPL Wealth Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.